Abstract
Skin cancer is the most common human malignancy. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) constitute approximately over 95 % (80 and 16 %, respectively) of new cases of non-melanoma skin cancers. It is estimated that over 1.3 million non-melanoma skin cancers will develop annually in the United States (Neville et al. 2007). Moreover, there are many conditions, especially actinic keratosis (AK) and Bowen’s disease, which can progress to invasive SCC. Treatment methods depend on the various clinical indications and histopathology of the malignancy. The three major therapeutic methods are topical application of chemotherapeutic agents, radiotherapy, and surgical management (Bolognia et al. 2003; Fitzpatrick et al. 2008). In this chapter, conventional therapeutic modalities for skin cancer managements will be briefly discussed and a new treatment modality using various beta-emitting radionuclides will be introduced.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Archambeau J, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol, Biol, Phys 31(5):1171–1185
Avril MF, Auperin A, Margulis A et al (1997) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76(1):100–106
Bladder H (1990) Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture. Photochem Photobiol 51(4):451–457
Bole P, HintzG P, Chan Y, Clauss R (1975) Bilateral carotid aneurysms secondary to radiation therapy. Ann Surg 181(6):888
Bolognia J, Jorizzo J, Rapini R (2003) Dermatology. Mosby, London
Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 21(3):293–302
Chung HS, Bang D, Lee JD, Sung YO, Park KB, Lee MG (1998) Treatment of multifocal Bowen’s disease with a specially designed radioactive skin patch. Br J Dermatol 139(5):938–939
Chung YL, Lee JD, Bang D, Lee JB, Park KB, Lee MG (2000) Treatment of Bowen’s disease with a specially designed radioactive skin patch. Eur J Nucl Med 27(7):842–846
Cox NH, Eedy DJ, Morton CA (2007) Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol 156(1):11–21
Cumberland L, Dana A, Liegeois N (2009) Mohs micrographic surgery for the management of nonmelanoma skin cancers. Facial Plast Surg Clin North Am 17(3):325–335
Datta SN, Loh CS, MacRobert AJ, Whatley SD, Matthews PN (1998) Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer 78(8):1113–1118
Dragieva G, Scharer L, Dummer R, Kempf W (2004) Photodynamic therapy—a new treatment option for epithelial malignancies of the skin. Onkologie 27(4):407–411
Drake LA, Dinehart SM, Goltz RW et al (1995) Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 33(2 Pt 1):271–278
Duncan KO, Leffell DJ (2003) Dermatology in general medicine, 6th edn. McGraw-Hill, New York
Dupree MT, Kiteley RA, Weismantle K, Panos R, Johnstone PA (2001) Radiation therapy for Bowen’s disease: lessons for lesions of the lower extremity. J Am Acad Dermatol 45(3):401–404
Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen K (2008) Dermatology in general medicine. McGraw-Hill, New York
Geisse J, Rich P, Pandya A et al (2002) Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47(3):390–398
Goldschmidt H, Panizzon R (1991) Modern dermatologic radiation therapy. Springer Verlag, New York
Hansen A, Hehrlein C, Hardt S et al (2001) Is the “candy-wrapper” effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound. Catheter Cardiovasc Interv 54(1):41–48
Jeong JM, Chung JK (2003) Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother Radiopharm 18(5):707–717
Jeong JM, Lee YJ, Kim EH et al (2003) Preparation of (188) Re-labeled paper for treating skin cancer. Appl Radiat Isot 58(5):551–555
Kay IP, Wardeh AJ, Kozuma K et al (2001) Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation 103(1):14–17
Kim HS, Chan RC, Kollum M et al (2001) Effects of 32P radioactive stents on in-stent restenosis in a double stent injury model of the porcine coronary arteries. Int J Radiat Oncol Biol Phys 51(4):1058–1063
Lane JE, Kent DE (2005) Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg 62(5):518–526
Lee JD, Park KK, Lee MG et al (1997) Radionuclide therapy of skin cancers and Bowen’s disease using a specially designed skin patch. J Nucl Med 38(5):697–702
Liu Y, Liu JL, Cai ZZ et al (2007) A novel approach for treatment of unresectable pancreatic cancer: design of radioactive stents and trial studies on normal pigs. Clin Cancer Res 13(11):3326–3332
Liu Y, Liu JL, Cai ZZ et al (2009a) A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointest Endosc 69(3 Pt 1):517–524
Liu Y, Lu Z, Zou DW et al (2009b) Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study. Gastrointest Endosc 69(6):1067–1073
Lovett RD, Perez CA, Shapiro SJ, Garcia DM (1990) External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 19(2):235–242
Marmur ES, Schmults CD, Goldberg DJ (2004) A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30(2 Pt 2):264–271
Minton TJ (2008) Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg 16(4):376–380
Moloney FJ, Collins P (2007) Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 157(1):87–91
Morton CA, Brown SB, Collins S et al (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4):552–567
Mukherjee A, Pandey U, Sarma H, Pillai M, Venkatesh M (2002) Preparation and evaluation of 90Y skin patches for therapy of superficial tumours in mice. Nucl Med Commun 23(3):243
Mukherjee A, Pandey U, Sarma HD et al (2003) Bioevaluation of radioactive bandages in a murine model of melanoma. Int J Radiat Biol 79(10):839–845
Neville JA, Welch E, Leffell DJ (2007) Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 4(8):462–469
Orengo I, Rosen T, Guill CK (2002) Treatment of squamous cell carcinoma in situ of the penis with 5 % imiquimod cream: a case report. J Am Acad Dermatol 47(4 Suppl):S225–S228
Pandey U, Sarma HD, Ingle AD, Kulloli BS, Samuel G, Venkatesh M (2006) Radioactive skin bandages incorporating P-32 for treatment of superficial tumors. Cancer Biother Radiopharm 21(3):257–262
Pandey U, Saxena SK, Sarma HD et al (2008) Bioevaluation studies of 32P incorporated mould brachytherapy sources for potential application in treatment of superficial tumors. Nucl Med Commun 29(8):717–723
Pariser D, Lowe N, Stewart D et al (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2):227–232
Persaud AN, Shamuelova E, Sherer D et al (2002) Clinical effect of imiquimod 5 % cream in the treatment of actinic keratosis. J Am Acad Dermatol 47(4):553–556
Rajpar S, Marsden J (2008) ABC of skin cancer. Malden, Blackwell Publishing
Rowe DE, Carroll RJ, Day CL Jr (1989a) Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15(4):424–431
Rowe DE, Carroll RJ, Day CL Jr (1989b) Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15(3):315–328
Salgueiro MJ, Duran H, Palmieri M et al (2008a) Design and bioevaluation of a 32P-patch for brachytherapy of skin diseases. Appl Radiat Isot 66(3):303–309
Salgueiro MJ, Duran H, Palmieri M et al (2008b) Bioevaluation of 32P patch designed for the treatment of skin diseases. Nucl Med Biol 35(2):233–237
Salgueiro MJ, Collia N, Barreiro ML et al (2009a) Radioactive treatment of a murine melanoma using a (32)P-patch. Nucl Med Commun 30(9):706–712
Salgueiro MJ, Collia N, Duran H et al (2009b) Biological effects of brachytherapy using a (32)P-patch on the skin of Sencar mice. Appl Radiat Isot 67(10):1769–1774
Sandberg C, Stenquist B, Rosdahl I et al (2006) Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 86(5):404–408
Serruys PW, Kay IP (2000) I like the candy, I hate the wrapper: the (32)P radioactive stent. Circulation 101(1):3–7
Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr (1998) Mohs micrographic surgery. J Am Acad Dermatol 39(1):79–97
Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ (1992) Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 18(7):549–554
Smeets NW, Kuijpers DI, Nelemans P et al (2004a) Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face—results of a retrospective study and review of the literature. Br J Dermatol 151(1):141–147
Smeets NW, Krekels GA, Ostertag JU et al (2004b) Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364(9447):1766–1772
Snow SN, Madjar DD Jr (2001) Mohs surgery in the management of cutaneous malignancies. Clin Dermatol 19(3):339–347
Szeimies RM, Karrer S, Radakovic-Fijan S et al (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47(2):258–262
Veness MJ (2008) The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol 52(3):278–286
Vora SA, Garner SL (2004) Role of radiation therapy for facial skin cancers. Clin Plast Surg 31(1):33–38
Watanabe S, Osa A, Sekine T et al (1999) Production of radioactive endovascular stents by implantation of 133Xe ions. Appl Radiat Isot 51(2):197–202
Weinberger J, Amols H, Ennis R, Schwartz A, Wiedermann J, Marboe C (1996) Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol, Biol, Phys 36(4):767–775
Won JH, Lee JD, Wang HJ et al (2002) Self-expandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. Int J Radiat Oncol Biol Phys 53(4):1005–1013
Won JH, Lee JD, Wang HJ et al (2005) Effects of a holmium-166 incorporated covered stent placement in normal canine common bile ducts. J Vasc Interv Radiol 16(5):705–711
Zeitouni NC, Oseroff AR, Shieh S (2003) Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39(17–18):1133–1136
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cho, A.EH., Lee, MG., Lee, J.D. (2012). Radionuclide Therapy for Skin Malignancies. In: Baum, R. (eds) Therapeutic Nuclear Medicine. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2012_712
Download citation
DOI: https://doi.org/10.1007/174_2012_712
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36718-5
Online ISBN: 978-3-540-36719-2
eBook Packages: MedicineMedicine (R0)